We recommend spatiotemporal exposure assessment (satellite-derived PM2.5/NO2, indoor biomass smoke measures, mold indices), coupled with endotype profiling (IgE, eosinophils, FeNO) to tailor interventions (e.g., anti-IL-5 for eosinophilic disease). The gene discussed is IGHE; the disease is eosinophil disorder.